{
  "actions": [
    {
      "acted_at": "2006-05-11", 
      "references": [
        {
          "reference": "CR S4476-4477", 
          "type": null
        }
      ], 
      "text": "Sponsor introductory remarks on measure.", 
      "type": "action"
    }, 
    {
      "acted_at": "2006-05-11", 
      "committee": "Committee on Health, Education, Labor, and Pensions", 
      "references": [], 
      "status": "REFERRED", 
      "text": "Read twice and referred to the Committee on Health, Education, Labor, and Pensions.", 
      "type": "referral"
    }
  ], 
  "amendments": [], 
  "bill_id": "s2793-109", 
  "bill_type": "s", 
  "committees": [
    {
      "activity": [
        "referral", 
        "in committee"
      ], 
      "committee": "Senate Health, Education, Labor, and Pensions", 
      "committee_id": "SSHR"
    }
  ], 
  "congress": "109", 
  "cosponsors": [
    {
      "district": null, 
      "name": "Roberts, Pat", 
      "sponsored_at": "2006-07-18", 
      "state": "KS", 
      "thomas_id": "00968", 
      "title": "Sen", 
      "withdrawn_at": null
    }
  ], 
  "enacted_as": null, 
  "history": {
    "active": false, 
    "awaiting_signature": false, 
    "enacted": false, 
    "vetoed": false
  }, 
  "introduced_at": "2006-05-11", 
  "number": "2793", 
  "official_title": "A bill to enhance research and education in the areas of pharmaceutical and biotechnology science and engineering, including therapy development and manufacturing, analytical technologies, modeling, and informatics.", 
  "popular_title": null, 
  "related_bills": [], 
  "short_title": "Pharmaceutical Technology and Education Enhancement Act", 
  "sponsor": {
    "district": null, 
    "name": "Lugar, Richard G.", 
    "state": "IN", 
    "thomas_id": "01387", 
    "title": "Sen", 
    "type": "person"
  }, 
  "status": "REFERRED", 
  "status_at": "2006-05-11", 
  "subjects": [
    "Commerce", 
    "Congress", 
    "Congressional reporting requirements", 
    "Drug industry", 
    "Economics and public finance", 
    "Education", 
    "Federal advisory bodies", 
    "Federal aid to education", 
    "Federal aid to research", 
    "Government operations and politics", 
    "Health", 
    "Higher education", 
    "Medical technology", 
    "Pharmaceutical research", 
    "Quality of products", 
    "Science, technology, communications"
  ], 
  "subjects_top_term": "Health", 
  "summary": {
    "as": "Introduced", 
    "date": "2006-05-11", 
    "text": "Pharmaceutical Technology and Education Enhancement Act - Requires the Commissioner of Food and Drugs to expand and intensify certain research and education programs regarding pharmaceutical science and engineering through the National Institute for Pharmaceutical Technology and Education (NIPTE) and its member institutions. Requires such programs to focus on medical therapy development and manufacturing, analytical technologies, modeling, and informatics. Requires the Commissioner to establish a Coordinating Committee to: (1) assist with and coordinate research and develop strategies for the rapid design, enhanced manufacturing process, and improved quality of new medical technology; and (2) develop a plan for supporting, through NIPTE and federal agency participants, research and education relating to medical technology development and manufacturing."
  }, 
  "titles": [
    {
      "as": "introduced", 
      "is_for_portion": false, 
      "title": "Pharmaceutical Technology and Education Enhancement Act", 
      "type": "short"
    }, 
    {
      "as": "introduced", 
      "is_for_portion": false, 
      "title": "A bill to enhance research and education in the areas of pharmaceutical and biotechnology science and engineering, including therapy development and manufacturing, analytical technologies, modeling, and informatics.", 
      "type": "official"
    }
  ], 
  "updated_at": "2013-07-19T20:37:52-04:00"
}